PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

Review Article

Volume 4 Issue 5

Critical Illness Myopathy: Pathophysiology and Management Strategies

Madhu Yadav A*, Rekha Assadi, Padmanaban Kandaswamy and V Kiran Kumar Reddy

April 26, 2024

DOI : 10.56831/PSMPH-04-141

View PDF

Abstract

Critical illness myopathy is a significant neuromuscular complication in critically ill patients, characterized by early proximal muscle weakness. It has varying incidences, significantly impacting mortality and morbidity among critically ill patients. This article aims to discuss the pathophysiology and evidence-based management strategies, which may help to improve patient outcomes in critically ill individuals.

Keywords: Critical Illness Myopathy; Early Mobilisation; Sedation

References

  1. Appleton Richard Td., et al. “The Incidence of Intensive Care Unit-Acquired Weakness Syndromes: A Systematic Review”. Journal of the Intensive Care Society 16.2 (2015): 126-36.
  2. Latronico Nicola and Charles F Bolton. “Critical Illness Polyneuropathy and Myopathy: A Major Cause of Muscle Weakness and Paralysis”. The Lancet Neurology 10.10 (2011): 931-41.
  3. De Letter MACJ., et al. “Critical Illness Polyneuropathy and Myopathy (CIPNM): Evidence for Local Immune Activation by Cytokine-Expression in the Muscle Tissue”. Journal of Neuroimmunology 106.1-2 (2000): 206-13.
  4. Helliwell., et al. “Muscle Fibre Atrophy in Critically Ill Patients Is Associated with the Loss of Myosin Filaments and the Presence of Lysosomal Enzymes and Ubiquitin”. Neuropathology and Applied Neurobiology 24.6 (1998): 507-17.
  5. Cheung Kevin., et al. “Pathophysiology and Management of Critical Illness Polyneuropathy and Myopathy”. Journal of Applied Physiology 130.5 (2021): 1479-89.
  6. Schefold Joerg C., et al. “Muscular Weakness and Muscle Wasting in the Critically Ill”. Journal of Cachexia, Sarcopenia and Muscle 11.6 (2020): 1399-412.
  7. Friedrich Oliver., et al. “Critical Illness Myopathy Serum Fractions Affect Membrane Excitability and Intracellular Calcium Release in Mammalian Skeletal Muscle”. Journal of Neurology 251.1 (2004): 53-65.
  8. De Letter Marie-An CJ., et al. “Risk Factors for the Development of Polyneuropathy and Myopathy in Critically Ill Patients’: Critical Care Medicine 29.12 (2001): 2281-86.
  9. Lacomis David., et al. “Critical Illness Myopathy”. Muscle & Nerve 23.12 (2000): 1785-88.
  10. Stevens Robert D., et al. “A Framework for Diagnosing and Classifying Intensive Care Unit-Acquired Weakness’: Critical Care Medicine 37 (2009): S299-308.
  11. Bednarík J., et al. “Risk Factors for Critical Illnesspolyneuromyopathy”. Journal of Neurology 252.3 (2005): 343-51.
  12. Hermans Greet., et al. “Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit”. American Journal of Respiratory and Critical Care Medicine 175.5 (2007): 480-89.
  13. Elliott Peter J., et al. “Proteasome Inhibition: A Novel Mechanism to Combat Asthma”. Journal of Allergy and Clinical Immunology 104.2 (1999): 294-300.
  14. Burtin Chris., et al. “Early Exercise in Critically Ill Patients Enhances Short-Term Functional Recovery*’: Critical Care Medicine 37.9 (2009): 2499-505.
  15. Riker Richard R. “Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized Trial”. JAMA 301.5 (2009): 489-99.
  16. Shanely R Andrew., et al. “Mechanical Ventilation-Induced Diaphragmatic Atrophy Is Associated with Oxidative Injury and Increased Proteolytic Activity”. American Journal of Respiratory and Critical Care Medicine 166.10 (2002): 1369-74.
  17. Gayan-Ramirez Ghislaine., et al. “Intermittent Spontaneous Breathing Protects the Rat Diaphragm from Mechanical Ventilation Effects”: Critical Care Medicine 33.12 (2005): 2804-09.
  18. Routsi Christina., et al. “Electrical Muscle Stimulation Prevents Critical Illness Polyneuromyopathy: A Randomized Parallel Intervention Trial”. Critical Care 14.2 (2010): R74.
  19. Hermans Greet., et al. “Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit”. American Journal of Respiratory and Critical Care Medicine 175.5 (2007): 480-89.
  20. Cacciani Nicola., et al. “Chaperone Co‐inducer BGP‐15 Mitigates Early Contractile Dysfunction of the Soleus Muscle in a Rat ICU Model”. Acta Physiologica 229.1 (2020): e13425.
  21. Akkad Hazem., et al. “Vamorolone Treatment Improves Skeletal Muscle Outcome in a Critical Illness Myopathy Rat Model”. Acta Physiologica 225.2 (2019): e13172.
  22. Addinsall Alex B., et al. “JAK/STAT Inhibition Augments Soleus Muscle Function in a Rat Model of Critical Illness Myopathy via Regulation of Complement C3/3R” The Journal of Physiology 599.11 (2021): 2869-86.